Leonard S. Schleifer, Chairman of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 20 sales on the open market. The latest trade was on 25/12/31.

LS

LS

Leonard S. Schleifer

Bd. Co-Chair, President & CEO

Company

Regeneron Pharmaceuticals REGN

First filing

23/05/17

Trades

36 trades

Buys / sales

0 / 20

12-month net buying

No record

Last trade

25/12/31

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/06/11–24/06/12	24/06/13	25,213 sh5 trades	$1,015.75avg.	$25,610,228.7	−100.0%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/06/06	24/06/10	787 sh	$1,015.02	$798,820.74	−1.2%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/05/17	24/05/17	22,830 sh2 trades	$979.23avg.	$22,355,714.15	−4.7%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	24/05/14–24/05/15	24/05/15	35,941 sh12 trades	$979.58avg.	$35,207,110.13	−8.3%